London's water contains high levels of antibiotic-resistant genes, UCL research reveals

Research from University College London has warned that freshwater sources in the English capital of London contain high levels of antibiotic-resistant genes.
These genes, excreted in human and animal waste after antibiotic use, can provide bacteria with resistance to common antibiotics including penicillin, erythromycin and tetracycline.
The River Thames was found to have the highest levels of the genes given its status as an ultimate destination for much of the city’s wastewater treatment operations, with other water sources including the Regent’s Canal, Regent’s Park Pond and the Serpentine also confirmed to be contaminated. Within these sources, antibiotic-resistant bacteria is provided with a prime environment to multiply and spread their resistance.
The team at UCL measured the level of antibiotic-resistant genes per litre of water in the various London water systems using a DNA-based methodology.
"This shows that more research is needed into the efficiency of different water treatment methods for antibiotic removal, as none of the treatments currently used were designed to incorporate this,” remarked UCL Civil, Environment and Geomatic Engineering’s Project Lead Dr Lena Ciric. "This is particularly important in the case of water bodies into which we discharge our treated wastewater, which currently still contains antibiotics. It is also important to look into the levels of antibiotics and resistant bacteria in our drinking water sources."
While unconfirmed, it is theorised that, because there is currently no legislation in place to support the removal of antibiotics or resistant genes from water sources, these genes could be present in London’s drinking water, though this would require testing.
The team is now working on removing the resistant bacteria and antibiotics in water taken from London’s water sources using slow sand filtration, a method used around the world to filter drinking water, experimenting with varying proportions of sand, activated carbon and different flow rates.
Matt Fellows
- Login or register to post comments
- Printer-friendly version
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Related content
- UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres
- The November 2020 issue of Pharmafocus is available to read free online now!
- UK life sciences industry does not want no-deal Brexit, says ABPI Chief
- MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme
- MSD unveils plans for $1.3bn central London research centre